Novo sees U.S. Tresiba launch 3-5 yrs after trial start

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said it hoped to launch its insulin Tresiba in the United States three to five years from the time it starts cardiovascular trials.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/05/novo-sees-us-tresiba-launch-3-5-yrs.html